CERS – Cerus Corporation
Cerus CorporationCERS
$1.60Name : Cerus Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $306,718,080.00
EPSttm : -0.1
Cerus Corporation
$1.60
0.62%$0.01Float Short %
6.15
Margin Of Safety %
-35
Put/Call OI Ratio
0.05
EPS Next Q Diff
0.02
EPS Last/This Y
0.01
EPS This/Next Y
0.07
Price
1.6
Target Price
4.67
Analyst Recom
1.5
Performance Q
7.38
Relative Volume
0.92
Beta
1.67
Ticker: CERS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | CERS | 1.305 | 0.09 | 0.00 | 6004 |
| 2025-09-09 | CERS | 1.29 | 0.09 | 0.00 | 5981 |
| 2025-09-10 | CERS | 1.17 | 0.09 | 0.01 | 5984 |
| 2025-09-11 | CERS | 1.24 | 0.09 | 0.29 | 6350 |
| 2025-09-12 | CERS | 1.235 | 0.08 | 0.00 | 6465 |
| 2025-09-15 | CERS | 1.205 | 0.08 | 0.00 | 6540 |
| 2025-09-16 | CERS | 1.255 | 0.08 | 0.00 | 6533 |
| 2025-09-17 | CERS | 1.23 | 0.080514766540175 | 0 | 6549 |
| 2025-09-18 | CERS | 1.31 | 0.07 | 0.00 | 6539 |
| 2025-09-22 | CERS | 1.51 | 0.06 | 0.15 | 7238 |
| 2025-09-23 | CERS | 1.62 | 0.06 | 0.00 | 7223 |
| 2025-09-24 | CERS | 1.545 | 0.06 | 0.02 | 7625 |
| 2025-09-25 | CERS | 1.52 | 0.06 | 0.00 | 7807 |
| 2025-09-26 | CERS | 1.435 | 0.05 | 0.00 | 7956 |
| 2025-09-29 | CERS | 1.525 | 0.05 | 0.08 | 7986 |
| 2025-09-30 | CERS | 1.59 | 0.05 | 0.01 | 7996 |
| 2025-10-01 | CERS | 1.52 | 0.05 | 0.00 | 8069 |
| 2025-10-02 | CERS | 1.515 | 0.05 | 0.00 | 8078 |
| 2025-10-03 | CERS | 1.575 | 0.05 | 0.00 | 8100 |
| 2025-10-06 | CERS | 1.605 | 0.05 | 0.00 | 8340 |
| 2025-10-07 | CERS | 1.595 | 0.05 | 0.00 | 8407 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | CERS | 1.30 | -25.0 | - | -0.10 |
| 2025-09-09 | CERS | 1.29 | -25.0 | - | -0.10 |
| 2025-09-10 | CERS | 1.17 | -25.0 | - | -0.10 |
| 2025-09-11 | CERS | 1.25 | -25.0 | - | -0.10 |
| 2025-09-12 | CERS | 1.24 | -25.0 | - | -0.10 |
| 2025-09-15 | CERS | 1.21 | -25.0 | - | -0.10 |
| 2025-09-16 | CERS | 1.26 | -25.0 | - | -0.10 |
| 2025-09-17 | CERS | 1.24 | -25.0 | - | -0.10 |
| 2025-09-18 | CERS | 1.31 | -25.0 | - | -0.10 |
| 2025-09-19 | CERS | 1.48 | -25.0 | - | -0.10 |
| 2025-09-22 | CERS | 1.51 | -25.0 | - | -0.10 |
| 2025-09-23 | CERS | 1.62 | -25.0 | - | -0.10 |
| 2025-09-24 | CERS | 1.54 | -25.0 | - | -0.10 |
| 2025-09-25 | CERS | 1.51 | -25.0 | - | -0.10 |
| 2025-09-26 | CERS | 1.44 | -25.0 | - | -0.10 |
| 2025-09-29 | CERS | 1.52 | -25.0 | - | -0.10 |
| 2025-09-30 | CERS | 1.60 | -25.0 | - | -0.10 |
| 2025-10-01 | CERS | 1.52 | -25.0 | - | -0.10 |
| 2025-10-02 | CERS | 1.51 | -25.0 | - | -0.10 |
| 2025-10-03 | CERS | 1.58 | -25.0 | - | -0.10 |
| 2025-10-06 | CERS | 1.61 | -25.0 | - | -0.10 |
| 2025-10-07 | CERS | 1.60 | -25.0 | - | -0.10 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | CERS | -4.43 | -3.07 | 5.44 |
| 2025-09-09 | CERS | -4.43 | -3.07 | 5.44 |
| 2025-09-10 | CERS | -4.43 | -3.07 | 5.44 |
| 2025-09-11 | CERS | -3.11 | -3.07 | 3.85 |
| 2025-09-12 | CERS | -3.11 | -3.07 | 3.85 |
| 2025-09-15 | CERS | -3.11 | -3.01 | 3.85 |
| 2025-09-16 | CERS | -3.11 | -3.01 | 3.85 |
| 2025-09-17 | CERS | -3.11 | -3.01 | 3.85 |
| 2025-09-18 | CERS | 0.20 | -3.01 | 3.85 |
| 2025-09-19 | CERS | 0.20 | -3.01 | 3.85 |
| 2025-09-22 | CERS | 0.20 | -3.01 | 3.85 |
| 2025-09-23 | CERS | 0.20 | -3.01 | 3.85 |
| 2025-09-24 | CERS | 0.20 | -3.01 | 3.85 |
| 2025-09-25 | CERS | 0.20 | -3.01 | 6.15 |
| 2025-09-26 | CERS | 0.20 | -3.01 | 6.15 |
| 2025-09-29 | CERS | 0.20 | -3.01 | 6.15 |
| 2025-09-30 | CERS | 0.20 | -3.01 | 6.15 |
| 2025-10-01 | CERS | 0.20 | -3.01 | 6.15 |
| 2025-10-02 | CERS | 0.20 | -3.01 | 6.15 |
| 2025-10-03 | CERS | 0.20 | -3.01 | 6.15 |
| 2025-10-06 | CERS | 0.20 | 1.46 | 6.15 |
| 2025-10-07 | CERS | 0.20 | 1.46 | 6.15 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.03
Avg. EPS Est. Current Quarter
-0.03
Avg. EPS Est. Next Quarter
-0.01
Insider Transactions
0.2
Institutional Transactions
1.46
Beta
1.67
Average Sales Estimate Current Quarter
55
Average Sales Estimate Next Quarter
58
Fair Value
1.05
Quality Score
41
Growth Score
51
Sentiment Score
63
Actual DrawDown %
82
Max Drawdown 5-Year %
-86.4
Target Price
4.67
P/E
Forward P/E
PEG
P/S
1.59
P/B
5.53
P/Free Cash Flow
89.69
EPS
-0.1
Average EPS Est. Cur. Y
-0.1
EPS Next Y. (Est.)
-0.03
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-9.81
Relative Volume
0.92
Return on Equity vs Sector %
-59.2
Return on Equity vs Industry %
-52.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Cerus CorporationSector: Healthcare
Industry: Medical Devices
Employees: 614
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
stock quote shares CERS – Cerus Corporation Stock Price stock today
news today CERS – Cerus Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CERS – Cerus Corporation yahoo finance google finance
stock history CERS – Cerus Corporation invest stock market
stock prices CERS premarket after hours
ticker CERS fair value insiders trading